PHARMASCROLL
enquiry@pharmascroll.com Mail Us
  • Home
  • About Us
    • Mission and Vision
    • Our Team
    • Why PharmaScroll
  • Business Intelligence
    • TreasureTell
  • Social Media Analytics
    • SocialBI
  • Market Research Services
  • Newsroom
    • Blog
    • Podcast
    • Press Release
    • Recent News
      • Neuroscience
        • Migraine
        • Multiple Sclerosis
        • Alzheimer’s
        • Parkinson’s
        • Epilepsy
        • Schizophrenia
        • Depression
        • ADHD
      • Respiratory
        • COPD
        • Asthma
        • Pulmonary Fibrosis
        • Cystic fibrosis
        • Rhinitis
      • Oncology
      • Diabetes
  • Careers
  • Contact Us
PHARMASCROLL
  • Home
  • About Us
    • Mission and Vision
    • Our Team
    • Why PharmaScroll
  • Business Intelligence
    • TreasureTell
  • Social Media Analytics
    • SocialBI
  • Market Research Services
  • Newsroom
    • Blog
    • Podcast
    • Press Release
    • Recent News
      • Neuroscience
        • Migraine
        • Multiple Sclerosis
        • Alzheimer’s
        • Parkinson’s
        • Epilepsy
        • Schizophrenia
        • Depression
        • ADHD
      • Respiratory
        • COPD
        • Asthma
        • Pulmonary Fibrosis
        • Cystic fibrosis
        • Rhinitis
      • Oncology
      • Diabetes
  • Careers
  • Contact Us
enquiry@pharmascroll.com Mail Us
HomeNewsNeuroscienceAlzheimer's
  • New Molecule shows potential to stop Alzheimer’s disease progression

    • May 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • PM20D1 gene associated with Alzheimer’s disease incidence, research finds

    • May 15, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Molecule could reduce Alzheimer’s degradation, study finds

    • May 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Anticholinergic drugs can increase Dementia risk in patients, study finds

    • May 9, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Early detection of Alzheimer’s disease expected with the help of Body-worn sensors

    • May 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Music makes Alzheimer’s symptoms more manageable, claims recent study

    • April 30, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Phase 2 Clinical Trial of GRF6019 in Alzheimer’s Disease initiated by Alkahest

    • April 26, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Amyloid blood biomarker detects Alzheimer’s disease

    • April 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Increasing Prevalence & Incidence rates for Alzheimer’s in Americans, report states

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • First Phase I candidate recruited for Jülich’s Alzheimer’s therapy

    • April 19, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • 1
  • 2
  • 3
  • 4
Recent Posts
  • Unlocking the Benefits of SocialBI for Patient Engagement
  • Predictive Analytics in Healthcare
  • Business Intelligence and Analytics in the Pharma Industry
  • Role of Patient Insights in Building Strong Healthcare
  • Social Media Analytics in Healthcare

Contact Us

  • Indian Address: PharmaScroll Research and Consulting Private Limited, 91 Springboard, 4th floor, F948+W7, Laxmi Cyber City, Whitefields, Hyderabad, Telangana 500081
  • US address: 12 Self Ct, Wallingford CT 06492
  • +919311760222
  • enquiry@pharmascroll.com

Recent Tweets

Could not authenticate you.

Recent Posts

  • Unlocking the Benefits of SocialBI for Patient Engagement
  • Predictive Analytics in Healthcare
  • Business Intelligence and Analytics in the Pharma Industry

News Letter

© 2025 Copyright. All rights reserved